LianBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	103.46	79.22	228.18	254.35
Short-Term Investments	148.77	223.14	155.07	0
Cash & Cash Equivalents	252.22	302.36	383.25	254.35
Cash Growth	-19.09%	-21.11%	50.68%	-
Receivables	0.91	1.77	6.04	20
Other Current Assets	4.67	8.64	10.35	2.4
Total Current Assets	257.81	312.77	399.65	276.75
Property, Plant & Equipment	5.01	7.09	6.65	2.53
Long-Term Investments	0.07	0.07	20	0
Other Long-Term Assets	0.02	0.02	0.05	0.01
Total Long-Term Assets	5.1	7.19	26.7	2.54
Total Assets	262.9	319.96	426.34	279.29
Accounts Payable	6.23	1.45	3.23	4.33
Current Debt	1.89	1.85	1.13	0.54
Other Current Liabilities	17.51	20.31	10.74	1.36
Total Current Liabilities	25.63	23.62	15.09	6.23
Long-Term Debt	0.95	2.49	3.71	1.34
Other Long-Term Liabilities	0.21	0.21	20.21	20
Total Long-Term Liabilities	1.16	2.7	23.92	21.34
Total Liabilities	26.79	26.31	39.01	27.57
Total Debt	2.84	4.34	4.83	1.88
Debt Growth	-40.36%	-10.24%	157.13%	-
Retained Earnings	-540.23	-470.53	-360.24	-163.94
Comprehensive Income	-3.22	-2.08	0.53	-0.04
Shareholders' Equity	202.34	259.87	353.56	-132.84
Net Cash / Debt	249.38	298.02	378.42	252.47
Net Cash / Debt Growth	-18.76%	-21.24%	49.89%	-
Net Cash Per Share	2.33	2.76	11.00	20.95
Working Capital	232.18	289.16	384.56	270.52
Book Value Per Share	1.89	2.41	10.28	-11.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).